Cardiology

A revised myocardial infarction classification, released during the ESC Congress 2026, replaces numerical labels with three clinical categories supporting more consistent diagnosis.

Findings from a large imaging study presented during ESC Congress 2026 suggested silent atherosclerosis present in more than half of adults without known cardiovascular disease.

New ESC guidelines call for routine CKD screening in patients with CVD, aiming to improve early diagnosis, optimise treatment, and reduce cardiovascular and kidney complications.

A real-world study found that polygenic risk score reclassified coronary artery disease risk in 42.6% of moderate risk patients and was associated with improvements in cardiovascular risk factors.

Updated ESC heart failure guidelines introduce simplified disease classifications, revised therapy categories, and recommendations supporting earlier intervention and evidence-based patient care.

First of all, the pioneers started the ESC 75 years ago. These were mainly colleagues from Sweden, France, Germany, and the UK…

The MAPLE-HCM trial shows aficamten improves exercise capacity and symptoms more than metoprolol in symptomatic obstructive hypertrophic cardiomyopathy.

In-hospital initiation of SGLT2 inhibitors is safe and may lower early cardiovascular death, worsening heart failure, and mortality in hospitalised patients.